Skip to content

Karl Doghramji, MD

NPI 1336229459ActiveIndividual· Psychiatry & Neurology, Sleep Medicine· Philadelphia, PA

Psychiatry & Neurology, Sleep Medicine (MD) in Philadelphia, Pennsylvania, licensed in PA and NJ, with an NPI issued in October 2006. Part D covered 32 prescriptions written in 2024, 81% of them generic. Jazz Pharmaceuticals Inc. was the largest of 2 companies reporting payments in 2025, $813.68 in all, mostly travel and lodging.

Overview

NPI1336229459
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedOct 16, 2006
Last updated in NPPESDec 14, 2015

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Psychiatry (NJ)

Part D prescriptions in 2024

Prescriptions (claims)32 · 52 30-day fills
Patients18
Total drug cost$6,621
Generic share81% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$813.68 · 4 payments from 2 companies
  • 2024$4,540 · 6 payments from 4 companies

Top paying companies in 2025

What the 2025 payments were for

  • Travel and Lodging$662.83 · 2 payments
  • Food and Beverage$134.29 · 1 payment
  • Education$16.56 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Psychiatry & Neurology, Sleep Medicine providers in Philadelphia

All Psychiatry & Neurology, Sleep Medicine providers in Pennsylvania